• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素及其低分子量衍生物新型一步凝血测定法的比较研究

Comparative study on a new one-stage clotting assay for heparin and its low molecular weight derivatives.

作者信息

Harenberg J, Giese C, Knödler A, Zimmermann R

机构信息

1st Department of Medicine, Klinikum Mannheim, University of Heidelberg, FRG.

出版信息

Haemostasis. 1989;19(1):13-20. doi: 10.1159/000215883.

DOI:10.1159/000215883
PMID:2537786
Abstract

The effects of a normal and a low molecular weight (LMW) heparin fraction were compared by four coagulation methods. Plasma samples of patients were investigated who were treated with normal heparin or with a LMW heparin. The study was undertaken to analyze the interrelationship between the coagulation methods: Heptest, activated partial thromboplastin time, thrombin clotting time, and S 2222 chromogenic anti-factor Xa test. The results showed a high correlation between Heptest and S 2222 anti-factor Xa method for unfractionated and LMW heparin (r = 0.91 and 0.90). Comparing the coagulation times in seconds of Heptest and aPTT, the correlations were r = 0.56 (normal heparin) and 0.15 (LMW heparin). The correlation between the coagulation times of Heptest and thrombin clotting time were r = 0.65 and 0.25, respectively. The correlations between the coagulation methods were higher, when coagulation times rather than transformed values to units per liter of the Heptest and of the S 2222 anti-factor Xa method were employed. Furthermore, the data demonstrate a high sensitivity of the Heptest to conventional and LMW heparin, whereas activated partial thromboplastin time and thrombin clotting time are less sensitive to either heparin. For laboratory control of LMW heparin, Heptest and S 2222 chromogenic method are reliable tests. Therapeutic ranges will have to be established.

摘要

通过四种凝血方法比较了普通肝素和低分子量(LMW)肝素组分的效果。对接受普通肝素或LMW肝素治疗的患者血浆样本进行了研究。开展该研究以分析凝血方法之间的相互关系:Heptest法、活化部分凝血活酶时间、凝血酶凝血时间和S 2222生色抗Xa因子试验。结果显示,对于普通肝素和LMW肝素,Heptest法与S 2222抗Xa因子法之间具有高度相关性(r = 0.91和0.90)。比较Heptest法和活化部分凝血活酶时间以秒为单位的凝血时间,相关性分别为r = 0.56(普通肝素)和0.15(LMW肝素)。Heptest法与凝血酶凝血时间的凝血时间之间的相关性分别为r = 0.65和0.25。当采用凝血时间而非将Heptest法和S 2222抗Xa因子法换算为每升单位的换算值时,凝血方法之间的相关性更高。此外,数据表明Heptest法对普通肝素和LMW肝素具有高敏感性,而活化部分凝血活酶时间和凝血酶凝血时间对任一种肝素的敏感性较低。对于LMW肝素的实验室监测,Heptest法和S 2222生色法是可靠的检测方法。必须确定治疗范围。

相似文献

1
Comparative study on a new one-stage clotting assay for heparin and its low molecular weight derivatives.肝素及其低分子量衍生物新型一步凝血测定法的比较研究
Haemostasis. 1989;19(1):13-20. doi: 10.1159/000215883.
2
Clinical evaluation of a new one-stage clotting assay for heparin and low molecular weight heparins.一种新型肝素和低分子肝素一步凝血检测法的临床评估
J Mal Vasc. 1987;12 Suppl B:68-70.
3
Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.使用抗Xa因子特异性全血凝血测定法监测血液透析中的肝素。
Nephrol Dial Transplant. 1995;10(2):217-22.
4
Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.肝素和低分子量肝素在治疗深静脉血栓形成中的剂量、抗凝及抗血栓作用
Semin Thromb Hemost. 1997;23(1):83-90. doi: 10.1055/s-2007-996074.
5
Anticoagulant effects and tissue factor pathway inhibitor after intrapulmonary low-molecular-weight heparin.肺内注射低分子量肝素后的抗凝作用及组织因子途径抑制剂
Blood Coagul Fibrinolysis. 1996 Jun;7(4):477-83. doi: 10.1097/00001721-199606000-00008.
6
Biological activity and safety of the subcutaneous administration of high doses of low molecular weight heparin for 8 days in human volunteers.
Thromb Haemost. 1989 Jun 30;61(3):357-62.
7
Effect of tissue factor pathway inhibitor (TFPI) in the HEPTEST assay and in an amidolytic anti factor Xa assay for LMW heparin.组织因子途径抑制剂(TFPI)在用于低分子量肝素的HEPTEST检测和酰胺水解抗Xa因子检测中的作用。
Thromb Haemost. 1992 Sep 7;68(3):310-4.
8
Monitoring of heparin and low molecular weight heparin with capillary and venous whole blood.
Thromb Haemost. 1988 Dec 22;60(3):377-81.
9
Laboratory monitoring of a low molecular weight heparin (enoxaparin) with a new clotting test (Heptest).使用新型凝血试验(七因子检测)对低分子量肝素(依诺肝素)进行实验室监测。
Haemostasis. 1987;17(3):127-33. doi: 10.1159/000215570.
10
Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparin.低分子量肝素和标准肝素预防血栓形成的实验室监测
Thromb Res. 1992 Jun 15;66(6):735-43. doi: 10.1016/0049-3848(92)90049-g.

引用本文的文献

1
Association of changes in D-dimer and other coagulation markers with changes in Marder score after treatment of acute venous thrombosis.急性静脉血栓形成治疗后D-二聚体及其他凝血标志物变化与Marder评分变化的相关性
J Thromb Thrombolysis. 2002 Aug;14(1):73-8. doi: 10.1023/a:1022022523146.